4.7 Article

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational studies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Effects of intensive glucose lowering in type 2 diabetes

Hertzel C. Gerstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Medicine, General & Internal

Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus

Shari Bolen et al.

ANNALS OF INTERNAL MEDICINE (2007)

Article Medicine, General & Internal

Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis

Philip D. Home et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes

Steven E. Nissen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Public, Environmental & Occupational Health

Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication

CE Koro et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)

Article Endocrinology & Metabolism

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study

M Gulliford et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)

Article Endocrinology & Metabolism

Association of hypoglycemia and cardiac ischemia - A study based on continuous monitoring

C Desouza et al.

DIABETES CARE (2003)